• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Calprotectin Correlates with Reduced Level of LVEF and Occurrence of Cardiac Arrhythmia in STEMI Patients.钙卫蛋白与ST段抬高型心肌梗死患者左心室射血分数降低及心律失常的发生相关。
Adv Biomed Res. 2024 Sep 23;13:90. doi: 10.4103/abr.abr_438_23. eCollection 2024.
2
In-hospital major adverse cardiovascular events after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: a retrospective study under the China chest pain center (standard center) treatment system.急性 ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗后的院内主要心血管不良事件：中国胸痛中心（标准版）治疗体系下的回顾性研究。
BMC Cardiovasc Disord. 2023 Apr 17;23(1):198. doi: 10.1186/s12872-023-03214-x.
3
Construction and evaluation of nomogram model for individualized prediction of risk of major adverse cardiovascular events during hospitalization after percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.急性ST段抬高型心肌梗死患者经皮冠状动脉介入治疗后住院期间主要不良心血管事件风险个体化预测列线图模型的构建与评估
Front Cardiovasc Med. 2022 Dec 21;9:1050785. doi: 10.3389/fcvm.2022.1050785. eCollection 2022.
4
Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With STEMI: The EXPLORE Trial.经皮介入治疗 ST 段抬高型心肌梗死合并慢性完全闭塞病变患者：EXPLORE 试验。
J Am Coll Cardiol. 2016 Oct 11;68(15):1622-1632. doi: 10.1016/j.jacc.2016.07.744.
5
High Serum Secreted Frizzled-Related Protein 5 Levels Associates with Early Improvement of Cardiac Function Following ST-Segment Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention.血清分泌型卷曲相关蛋白 5 水平与经皮冠状动脉介入治疗 ST 段抬高型心肌梗死患者心功能早期改善相关。
J Atheroscler Thromb. 2019 Oct 1;26(10):868-878. doi: 10.5551/jat.47019. Epub 2019 Feb 15.
6
Improved heart function and cardiac remodelling following sacubitril/valsartan in acute coronary syndrome with HF.沙库巴曲缬沙坦治疗急性冠脉综合征合并心力衰竭患者的心脏功能改善和心脏重构。
ESC Heart Fail. 2024 Apr;11(2):937-949. doi: 10.1002/ehf2.14646. Epub 2024 Jan 15.
7
Magnetic Resonance Assessment of Left Ventricular Ejection Fraction at Any Time Post-Infarction for Prediction of Subsequent Events in a Large Multicenter STEMI Registry.磁共振评估梗死后任意时间左心室射血分数对大型多中心 STEMI 注册中心后续事件的预测。
J Magn Reson Imaging. 2022 Aug;56(2):476-487. doi: 10.1002/jmri.27789. Epub 2021 Jun 16.
8
Rapid predictors for the occurrence of reduced left ventricular ejection fraction between LAD and non-LAD related ST-elevation myocardial infarction.左前降支相关与非左前降支相关ST段抬高型心肌梗死之间左心室射血分数降低发生的快速预测因素。
BMC Cardiovasc Disord. 2016 Jan 5;16:3. doi: 10.1186/s12872-015-0178-y.
9
One-year Outcomes in Patients with ST-segment Elevation Myocardial Infarction Caused by Unprotected Left Main Coronary Artery Occlusion Treated by Primary Percutaneous Coronary Intervention.直接经皮冠状动脉介入治疗无保护左主干冠状动脉闭塞所致 ST 段抬高型心肌梗死患者 1 年的转归。
Chin Med J (Engl). 2018 Jun 20;131(12):1412-1419. doi: 10.4103/0366-6999.233948.
10
Prognostic impact of left ventricular ejection fraction recovery in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: analysis of an 11-year all-comers registry.ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗后左心室射血分数恢复的预后影响：一项 11 年所有患者登记研究的分析。
Eur Heart J Acute Cardiovasc Care. 2021 Oct 27;10(8):898-908. doi: 10.1093/ehjacc/zuab058.

引用本文的文献

1
Epidemiological and Translational Study of Calprotectin and Atherosclerotic Cardiovascular Disease.钙卫蛋白与动脉粥样硬化性心血管疾病的流行病学及转化研究
JAMA Cardiol. 2025 May 7. doi: 10.1001/jamacardio.2025.0945.

本文引用的文献

1
Calprotectin and periostin levels in periodontitis patients with coronary artery disease.患有冠状动脉疾病的牙周炎患者的钙卫蛋白和骨膜蛋白水平
Oral Dis. 2024 May;30(4):2625-2634. doi: 10.1111/odi.14686. Epub 2023 Jul 27.
2
Calprotectin: from biomarker to biological function.钙卫蛋白：从生物标志物到生物学功能。
Gut. 2021 Oct;70(10):1978-1988. doi: 10.1136/gutjnl-2021-324855. Epub 2021 Jun 18.
3
Calprotectin and Neutrophil Gelatinase-Associated Lipocalin As Biomarkers of Acute Kidney Injury in Acute Coronary Syndrome.钙卫蛋白和中性粒细胞明胶酶相关载脂蛋白作为急性冠状动脉综合征急性肾损伤的生物标志物。
Am J Med Sci. 2021 Jun;361(6):736-743. doi: 10.1016/j.amjms.2020.10.028. Epub 2020 Nov 2.
4
An evaluation of lipid profile and pro-inflammatory cytokines as determinants of cardiovascular disease in those with diabetes: a study on a Mexican American cohort.评估血脂谱和促炎细胞因子作为糖尿病患者心血管疾病的决定因素：一项对墨西哥裔美国人队列的研究。
Sci Rep. 2021 Jan 28;11(1):2435. doi: 10.1038/s41598-021-81730-6.
5
Association of Lipid, Inflammatory, and Metabolic Biomarkers With Age at Onset for Incident Coronary Heart Disease in Women.脂质、炎症和代谢生物标志物与女性冠心病发病年龄的关联。
JAMA Cardiol. 2021 Apr 1;6(4):437-447. doi: 10.1001/jamacardio.2020.7073.
6
Plasma calprotectin was associated with platelet activation and no-reflow phenomenon in acute coronary syndrome.血浆钙卫蛋白与急性冠脉综合征中的血小板活化和无复流现象有关。
BMC Cardiovasc Disord. 2020 Oct 9;20(1):443. doi: 10.1186/s12872-020-01717-5.
7
Prognostic value of serum calprotectin level in elderly diabetic patients with acute coronary syndrome undergoing percutaneous coronary intervention: A Cohort study.血清钙卫蛋白水平对接受经皮冠状动脉介入治疗的老年急性冠状动脉综合征糖尿病患者的预后价值：一项队列研究。
Medicine (Baltimore). 2020 Aug 14;99(33):e20805. doi: 10.1097/MD.0000000000020805.
8
Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis.血清钙卫蛋白：类风湿关节炎和中轴型脊柱关节炎有前景的生物标志物。
Arthritis Res Ther. 2020 May 6;22(1):105. doi: 10.1186/s13075-020-02190-3.
9
Efficacy and Safety of Pharmacoinvasive Strategy Compared to Primary Percutaneous Coronary Intervention in the Management of ST-Segment Elevation Myocardial Infarction: A Prospective Country-Wide Registry.在ST段抬高型心肌梗死管理中，药物介入策略与直接经皮冠状动脉介入治疗相比的疗效和安全性：一项全国性前瞻性登记研究。
Ann Glob Health. 2020 Feb 5;86(1):13. doi: 10.5334/aogh.2632.
10
Familial hypercholesterolemia and elevated lipoprotein(a): double heritable risk and new therapeutic opportunities.家族性高胆固醇血症和脂蛋白(a)升高：双重遗传性风险和新的治疗机会。
J Intern Med. 2020 Jan;287(1):2-18. doi: 10.1111/joim.12981.

钙卫蛋白与ST段抬高型心肌梗死患者左心室射血分数降低及心律失常的发生相关。

Calprotectin Correlates with Reduced Level of LVEF and Occurrence of Cardiac Arrhythmia in STEMI Patients.

作者信息

Haybar Habib, Ramezani Babak, Assareh Ahmad Reza, Kardooni Ali, Azizidoost Shirin

机构信息

Atherosclerosis Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Department of Cardiology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

出版信息

Adv Biomed Res. 2024 Sep 23;13:90. doi: 10.4103/abr.abr_438_23. eCollection 2024.

DOI:10.4103/abr.abr_438_23
PMID:39512407
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11542697/
Abstract

BACKGROUND

Calprotectin is recognized as a promising prognostic as well as a diagnostic marker of cardiac disorders. In the present study, we aimed to survey the efficiency of serum calprotectin levels in anticipating the severity of coronary artery disease (CAD) along with in-hospital major adverse cardiovascular events (MACE) in patients with ST-segment elevation (STEMI) underlying primary percutaneous coronary intervention (PCI).

MATERIALS AND METHODS

A total of 97 patients with STEMI participated and were evaluated for in-hospital MACE for possible correlation with serum calprotectin.

RESULTS

Increased levels of serum calprotectin showed positive and negative correlation with severity of coronary arteries and left ventricular ejection fraction (LVEF) of STEMI patients, respectively. Regarding in-hospital MACE, only arrhythmia showed a significant relationship in patients with high calprotectin levels.

CONCLUSION

High calprotectin levels may be a prognostic marker for occluded artery and LVEF in STEMI patients.

摘要

背景

钙卫蛋白被认为是一种有前景的心脏疾病预后及诊断标志物。在本研究中，我们旨在调查血清钙卫蛋白水平在预测ST段抬高型心肌梗死（STEMI）患者接受直接经皮冠状动脉介入治疗（PCI）时冠状动脉疾病（CAD）的严重程度以及院内主要不良心血管事件（MACE）方面的效能。

材料与方法

共有97例STEMI患者参与研究，并对其进行院内MACE评估，以探讨其与血清钙卫蛋白的可能相关性。

结果

血清钙卫蛋白水平升高分别与STEMI患者冠状动脉严重程度及左心室射血分数（LVEF）呈正相关和负相关。关于院内MACE，仅心律失常在高钙卫蛋白水平患者中显示出显著相关性。

结论

高钙卫蛋白水平可能是STEMI患者动脉闭塞和LVEF的预后标志物。